
Sarcomatrix, a specialty pharmaceutical company, is developing novel drugs to treat a variety of muscle wasting diseases, sarcopenia, cachexia and muscular dystrophies. Total market potential greater than $50B.
Only investors and funding providers that are registered through us can view the attached business plan and contact this member for funding.
Sarcomatrix, a specialty pharmaceutical company, is developing novel drugs to treat a variety of muscle wasting diseases, sarcopenia, cachexia and muscular dystrophies. Total market potential greater than $50B.